Zhang Lei, Xu Jiarui, Li Xiaoye, Zhang Xiaochun, Pan Wenzhi, Guan Lihua, Ding Xiaoqiang, Zhou Daxin, Ge Junbo
Department of Cardiology, Zhongshan Hospital, Fudan University, 200032 Shanghai, China.
National Clinical Research Center for Interventional Medicine, 200032 Shanghai, China.
Rev Cardiovasc Med. 2022 Sep 9;23(9):306. doi: 10.31083/j.rcm2309306. eCollection 2022 Sep.
This study aimed to investigate the predictors and prognosis of acute kidney injury (AKI) occurrence among Chinese patients following left atrial appendage closure (LAAC).
We retrospectively enrolled 512 consecutive patients who underwent LAAC between January 2014 and December 2019. AKI was clinically defined according to the Kidney Disease Improving Global Outcomes serum creatinine criteria. Major adverse cardiovascular events were defined as the composite of all-cause mortality, readmission due to heart failure, cardiac surgery, systemic embolism, or bleeding events.
The incidence of AKI was 5.3% and was highest in patients with chronic kidney disease (CKD) stages 4-5 (25.0%), followed by those with CKD stages 3a-3b (9.1%), and those with CKD stages 1-2 or without CKD (3.9% only). Multivariate logistic regression showed that lower body mass index (odds ratio [OR] = 0.889; 95% confidence interval [CI], 0.803-0.986; = 0.017), hypertension (OR = 5.577; 95% CI, 1.267-24.558; = 0.023), and CKD stages 4-5 (OR = 6.729; 95% CI, 1.566-28.923; = 0.010) were independent risk factors for AKI development after LAAC. AKI after LAAC was associated with 3-year major adverse cardiovascular events (33.3% vs. 7.5%, 0.001) and all-cause mortality (11.1% vs. 0.9%, 0.001) compared to that in the non-AKI group.
AKI is relatively common after LAAC in patients with a baseline impaired glomerular filtration rate. Moreover, AKI after LAAC is mainly related to increased midterm mortality and morbidity, which require more strategies for prevention and treatment.
本研究旨在调查中国患者左心耳封堵术(LAAC)后急性肾损伤(AKI)发生的预测因素及预后情况。
我们回顾性纳入了2014年1月至2019年12月期间连续接受LAAC的512例患者。AKI根据改善全球肾脏病预后组织的血清肌酐标准进行临床定义。主要不良心血管事件定义为全因死亡率、因心力衰竭再次入院、心脏手术、系统性栓塞或出血事件的综合情况。
AKI的发生率为5.3%,在慢性肾脏病(CKD)4 - 5期患者中最高(25.0%),其次是CKD 3a - 3b期患者(9.1%),以及CKD 1 - 2期或无CKD的患者(仅3.9%)。多因素逻辑回归显示,较低的体重指数(比值比[OR]=0.889;95%置信区间[CI],0.803 - 0.986;P = 0.017)、高血压(OR = 5.577;95% CI,1.267 - 24.558;P = 0.023)和CKD 4 - 5期(OR = 6.729;95% CI,1.566 - 28.923;P = 0.010)是LAAC后AKI发生的独立危险因素。与非AKI组相比,LAAC后发生AKI与3年主要不良心血管事件(33.3%对7.5%,P < 0.001)和全因死亡率(11.1%对0.9%,P < 0.001)相关。
基线肾小球滤过率受损的患者LAAC后AKI相对常见。此外,LAAC后AKI主要与中期死亡率和发病率增加有关,这需要更多的预防和治疗策略。